| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.15▼ | 3.19▼ | 3.20▼ | 3.28▼ | 4.14▼ |
| MA10 | 3.16▼ | 3.21▼ | 3.21▼ | 3.35▼ | 4.61▼ |
| MA20 | 3.19▼ | 3.22▼ | 3.25▼ | 4.01▼ | 5.16▼ |
| MA50 | 3.21▼ | 3.30▼ | 3.39▼ | 4.91▼ | 8.38▼ |
| MA100 | 3.22▼ | 3.40▼ | 3.61▼ | 5.18▼ | N/A |
| MA200 | 3.28▼ | 3.70▼ | 4.29▼ | 7.67▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.001▼ | -0.002▼ | -0.040▼ | -0.029▼ |
| RSI | 40.936▼ | 35.110▼ | 34.231▼ | 35.600▼ | 38.431▼ |
| STOCH | 31.944 | 45.565 | 40.888 | 10.671▼ | 13.980▼ |
| WILL %R | -57.143 | -78.571▼ | -87.500▼ | -97.826▼ | -99.459▼ |
| CCI | -88.315 | -129.515▼ | -136.709▼ | -106.162▼ | -116.996▼ |
|
Monday, June 02, 2025 12:24 PM
Morgan Stanley resumed its coverage of Alumis Inc. (NASDAQ:ALMS) with an Overweight rating and a $23 price target after the company’s recent merger with Acelyrin and its Q1 2025 earnings release. A ...
|
|
Thursday, May 29, 2025 07:53 AM
Alumis Inc. (NASDAQ:ALMS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus estimated revenue numbers rose ...
|
|
Monday, May 19, 2025 04:59 PM
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.17 | 3.269 | 3.10 | 3.14 | 637,400 |
| 12/06/25 | 3.27 | 3.37 | 3.15 | 3.18 | 816,300 |
| 11/06/25 | 3.40 | 3.40 | 3.27 | 3.29 | 741,000 |
| 10/06/25 | 3.47 | 3.56 | 3.355 | 3.365 | 765,008 |
| 09/06/25 | 3.60 | 3.70 | 3.37 | 3.43 | 608,802 |
| 06/06/25 | 3.35 | 3.85 | 3.32 | 3.59 | 995,000 |
| 05/06/25 | 3.40 | 3.54 | 3.251 | 3.35 | 742,100 |
| 04/06/25 | 3.43 | 3.77 | 3.39 | 3.41 | 551,738 |
| 03/06/25 | 3.30 | 3.77 | 3.25 | 3.45 | 1,702,272 |
| 02/06/25 | 3.60 | 3.60 | 3.26 | 3.29 | 1,312,865 |
|
|
||||
|
|
||||
|
|